首页> 外文期刊>World Journal of Surgical Oncology >Identification of a prognostic gene signature of colon cancer using integrated bioinformatics analysis
【24h】

Identification of a prognostic gene signature of colon cancer using integrated bioinformatics analysis

机译:用综合生物信息学分析鉴定结肠癌的预后基因特征

获取原文
           

摘要

Colon cancer is a worldwide leading cause of cancer-related mortality, and the prognosis of colon cancer is still needed to be improved. This study aimed to construct a prognostic model for predicting the prognosis of colon cancer. The gene expression profile data of colon cancer were obtained from the TCGA, GSE44861, and GSE44076 datasets. The WGCNA module genes and common differentially expressed genes (DEGs) were used to screen out the prognosis-associated DEGs, which were used to construct a prognostic model. The performance of the prognostic model was assessed and validated in the TCGA training and microarray validation sets (GSE38832 and GSE17538). At last, the model and prognosis-associated clinical factors were used for the construction of the nomogram. Five colon cancer-related WGCNA modules (including 1160 genes) and 1153 DEGs between tumor and normal tissues were identified, inclusive of 556 overlapping DEGs. Stepwise Cox regression analyses identified there were 14 prognosis-associated DEGs, of which 12 DEGs were included in the optimized prognostic gene signature. This prognostic model presented a high forecast ability for the prognosis of colon cancer both in the TCGA training dataset and the validation datasets (GSE38832 and GSE17538; AUC 0.8). In addition, patients’ age, T classification, recurrence status, and prognostic risk score were associated with the prognosis of TCGA patients with colon cancer. The nomogram was constructed using the above factors, and the predictive 3- and 5-year survival probabilities had high compliance with the actual survival proportions. The 12-gene signature prognostic model had a high predictive ability for the prognosis of colon cancer.
机译:结肠癌是全球癌症相关死亡的主要原因,仍然需要改善结肠癌的预后。本研究旨在构建预测结肠癌预后的预后模型。从TCGA,GSE44861和GSE44076数据集获得结肠癌的基因表达谱数据。 WGCNA模块基因和常见的差异表达基因(DEGS)用于筛选用于构建预后模型的预后相关的DEG。在TCGA培训和微阵列验证集(GSE38832和GSE17538)中评估和验证了预后模型的性能。最后,模型和预后相关的临床因素用于构建墨迹图。鉴定了五种结肠癌相关的WGCNA模块(包括1160个基因)和1153℃,肿瘤和正常组织之间,包括556个重叠的次数。逐步的Cox回归分析鉴定有14个预后相关的次数,其中包含12只DEG的优化预后基因签名。该预后模型在TCGA训练数据集和验证数据集中介绍了结肠癌预后的高预测能力(GSE38832和GSE17538; AUC> 0.8)。此外,患者的年龄,T分类,复发状态和预后风险评分与TCGA患者的结肠癌患者的预后有关。使用上述因素构建了NOM图,预测性3和5年的存活概率高符合实际存活率比例。 12-基因签名预后模型具有高预测性的结肠癌预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号